Columnist Desiree Lama has always known she wanted to help people; now she is achieving that goal through MS advocacy.

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Vaccination didn't increase the risk of children or adolescents being diagnosed with pediatric MS within five years, a study ...

Nabiximols and other cannabis-based treatments were seen to work well at controlling spasticity, though responses vary among ...

Tiziana's Phase 2 trial testing foralumab for nonactive secondary progressive multiple sclerosis (SPMS) has added six U.S.

Children with MS from poorer families or other disadvantaged circumstances tend to have more inflammation and brain damage, a ...

Higher levels of cholesterol in people with multiple sclerosis (MS) are associated with cognitive impairment, a study found.

MS patients undergoing hematopoietic stem cell transplant (HSCT) face physical and emotional challenges at each treatment ...

When faced with the obstacle course that is MS, columnist Ben Hofmeister remembers his strategy while in the Army Special Forces: Don't quit.

Hospitalization for severe COVID-19 more than doubles risk of MS, according to a study involving nearly 10 million people in ...

The FDA cleared an extended version of Neurophet AQUA that uses AI for analysis in counting and measuring MS brain lesions on ...

Columnist Desiree Lama, now a graduate student, explains why she never pursued academic accommodations to help her navigate ...